脂肪酸結(jié)合蛋白5(FABP5)活性蛋白
Active Fatty Acid Binding Protein 5 (FABP5)
E-FABP; EFABP; PA-FABP; PAFABP; Fatty Acid Binding Protein 5, Epidermal; Psoriasis-Associated; Epidermal-type fatty acid-binding protein; Psoriasis-associated fatty acid-binding protein homolog
- 編號(hào)APB985Mu01
- 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)6.7
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1536 ¥ 3840¥ 7680¥ 23040¥ 57600
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)

Fatty Acid Binding Protein 5 (FABP5) ,?is a 15-kDa cytosolic protein abundant in epidermal keratinocytes, macrophages, and adipocytes. As a member of the FABP family, it selectively binds long-chain fatty acids and retinoids, shuttling ligands to nuclear receptors to regulate gene transcription. In the skin, FABP5 drives epidermal differentiation and inflammation by modulating lipid mediator biosynthesis . It also acts as a redox sensor, protecting against oxidative stress in psoriasis and wound healing. Furthermore, the interaction between FABP5 and S100A7 augments pro-inflammatory signaling and cancer cell migration by orchestrating lipid-mediated pathways and inflammatory cytokine production.Thus a functional ELISA assay was conducted to detect the interaction of recombinant mouse FABP5 and recombinant human S100A7. Briefly,FABP5 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to S100A7-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-LOX pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant mouse FABP5 and recombinant human S100A7 was shown in Figure 1, the EC50?for this effect is 0.447ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB985Mu01 | 脂肪酸結(jié)合蛋白5(FABP5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB985Mu01 | 脂肪酸結(jié)合蛋白5(FABP5)活性蛋白 | Cell?culture;?Activity?Assays. |
PAB985Mu01 | 脂肪酸結(jié)合蛋白5(FABP5)多克隆抗體 | WB |
PAB985Mu02 | 脂肪酸結(jié)合蛋白5(FABP5)多克隆抗體 | WB; IHC; ICC; IP. |
PAB985Mu51 | 脂肪酸結(jié)合蛋白5(FABP5)多克隆抗體 | WB; IHC; ICC; IP. |
LAB985Mu81 | 脂肪酸結(jié)合蛋白5(FABP5)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAB985Mu71 | 脂肪酸結(jié)合蛋白5(FABP5)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
SEB985Mu | 脂肪酸結(jié)合蛋白5(FABP5)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB985Mu | 脂肪酸結(jié)合蛋白5(FABP5)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSB985Mu01 | 脂肪酸結(jié)合蛋白5(FABP5)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | 自己動(dòng)手制作ELISA試劑盒的主要材料 |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Journal of Proteome Research | Profiling Protein Markers Associated with Lymph Node Metastasis in Prostate Cancer by DIGE-based Proteomics Analysis[PubMed: 19894759] |
PLoS One | Circulating Levels of Fatty Acid-Binding Protein Family and Metabolic Phenotype in the General Population[Pubmed: 24278421] |
PLOS?ONE | Transcriptome?and?Metabolome?Analyses?in?Exogenous?FABP4- and?FABP5-Treated?Adipose-Derived?Stem?Cells.[pubmed:27936164] |
Sci Rep. | Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.[pubmed:28303004] |